Rilzabrutinib

wAIHA | Rilzabrutinib Receives FDA Breakthrough Therapy Designation

Warm autoimmune haemolytic anaemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells, leading to anemia and other serious complications, such as significant fatigue, dizziness,…

Read More »